RHOC and head and neck squamous cell carcinoma: Inhibition of RhoC geranylgeranylation by atorvastatin caused inhibition of melanoma cell metastasis and reduced pSer727 STAT3 levels in a head and neck squamous cancer carcinoma (HNSCC) [51,52].